RE: OO & Codagenix Nasal Covid-19 vaccine clinical trial20 Feb 2021 13:35
Taken from the RNS...
We at the Serum Institute of India are pleased with the MHRA approval for initiating the first-in-human clinical trial for the novel intranasal product against COVID-19, developed by Codagenix in collaboration with SII. We are happy to have hVIVO conducting the clinical trial of this unique Intranasal vaccine